European VC Funds

Momenta is a leading venture capital firm specializing in Industrial Impact investments, focusing on digital innovators in sectors such as energy, manufacturing, smart spaces, and supply chain. They have a decade-long track record of scaling companies that drive significant industrial and environmental improvements. Notable portfolio companies include Tvarit, Fleet Space, FreeWire, and EquipmentShare, which reflect their emphasis on impactful, scalable technologies. Momenta's investment strategy involves early-stage funding and close collaboration with founders to foster business growth. They leverage a robust network of industrial partners and extensive industry experience to support their portfolio companies, offering more than just financial backing. Their approach includes strategic advice, connections to potential customers and partners, and assistance with market positioning and scaling operations. Geographically, Momenta operates across Europe and North America, with key team members based in cities like Seattle, Luzern, and San Francisco. The team includes experienced professionals like Michael Dolbec and Douglas Harp, who bring decades of expertise in digital transformation, industrial IoT, and strategic business development. Startups seeking investment should demonstrate innovative solutions with the potential for significant industrial impact. Momenta values strong leadership teams and scalable business models that align with their mission of driving digital transformation and sustainability in critical industries.

Monthly Ventures is a San Francisco boutique seed-stage venture capital fund founded in 2013 by Yuri Rabinovich. Closely associated with the Startup Monthly community Rabinovich built in the Bay Area, the firm operates as an entrepreneur-led micro-fund with a sweet-spot check size of approximately USD 100,000 and a stated range of $50,000 to $200,000. The fund targets early-stage companies at pre-seed and seed stages across enterprise applications, consumer, and enterprise infrastructure, with the majority of investments in the United States and selective coverage in Romania and the United Kingdom. Over its active deployment period Monthly Ventures backed 16 early-stage startups that collectively went on to raise roughly USD 26 million in follow-on funding. Across 11 disclosed portfolio companies the firm has recorded one exit. The most prominent portfolio name is Lenda, a digital mortgage originator that raised USD 11.5 million across nine rounds before being acquired by Reali in April 2019 — the firm's most notable realized investment. Additional portfolio names include Proto. Managing Partner Yuri Rabinovich has since launched a successor vehicle, VNTR Capital, which serves as his primary investing platform. Monthly Ventures itself has been largely dormant in terms of new-investment activity in recent years. The fund's small scale, fee-light structure, and founder-community roots reflect the micro-VC model common to the early 2010s Bay Area ecosystem.

Moonfire Ventures is a London-based pre-seed and seed-stage venture capital firm founded in 2020 by Mattias Ljungman, a Swedish investor who spent 13 years as a co-founder of Atomico before leaving in 2019 to build Moonfire. The firm positions itself not as a traditional VC but as a technology company that does venture capital, deploying proprietary machine-learning and generative-AI tooling that reviews up to 50,000 companies per week — roughly 600 times the throughput of a typical fund — to systematically surface Europe's best early-stage founders and augment human judgement with data-driven signals. Partner Mike Arpaia, a computer scientist with an AI and quantitative-finance background and former tech lead at Facebook, Etsy, and Workday, co-founded the cybersecurity platform Kolide before joining Moonfire. Around 90% of the team are former founders themselves. Moonfire has raised two vehicles: Fund I at $60 million in 2020-2021, and a $115 million Fund II in May 2023 (split between a $90 million main fund and a $25 million opportunity fund), with Cendana as a primary LP alongside Utah School and Institutional Trust Funds Office and US state endowments. The firm leads rounds and writes typical tickets of $1 million to $2.5 million. The portfolio spans 46 companies across AI, SaaS, fintech, cybersecurity, gaming, healthtech, and future-of-work. Recent investments include Filigran ($35 million Series B, cybersecurity), Flexion Robotics (EUR 43 million, November 2025), Fleet Device Management ($27 million Series B, June 2025), and Neuphonic (voice AI). Additional portfolio names include Humaans, Lingo.dev, and Bloom. Moonfire's AI-assisted sourcing model is designed to reduce the pattern-matching biases inherent in traditional VC and to discover exceptional founders from geographies and backgrounds that conventional networks tend to overlook.

Moonstone is an Italian pre-seed and seed-stage impact venture capital firm founded in May 2023 and headquartered in Milan, with additional operations in the United Kingdom. The firm invests sector- and geography-agnostically in founders solving systemic, impactful problems for people and the planet, with a deliberate tilt toward deep tech, healthcare, climate tech, and clean tech. Moonstone is led by CEO Jacopo Mele and Investment Manager Chiara Castelli, with a team of approximately 29 people including six partners, twelve venture partners, and eight principals spanning Italy and the UK. Moonstone leads rounds. The firm's initial model makes small first checks of up to approximately EUR 50,000 across a broad cohort of around 60 founders per plan, then concentrates follow-on capital into proven winners through co-investment in subsequent rounds. The selection process typically concludes in two weeks or fewer. As of October 2025 Moonstone has invested in 34 companies, with four new investments in the preceding twelve months. In 2025 the firm backed Jack Fertility, Messium, Foreverland, and Make it REAL. Notably, Moonstone co-led a $3.79 million seed round in Italian foodtech startup Foreverland — maker of Choruba, a carob-based chocolate alternative — alongside Exor, with participation from CDP Venture Capital. Portfolio sectors span enterprise applications, food and agriculture, sustainability tech, enterprise infrastructure, and the environment. Moonstone operates with a 'nose in, hands out' philosophy, providing access to its network and expertise without micromanaging founders. The firm's broad venture-partner base gives portfolio companies access to domain experts across climate, health, and deep-tech commercialization at a stage when such guidance is most scarce.

Morgan Creek Capital, founded by Mark Yusko, is a prominent venture capital firm based in Chapel Hill, North Carolina. Established in 2018, Morgan Creek Digital, a division of Morgan Creek Capital, focuses on early-stage investments in blockchain technology, digital assets, and other innovative sectors such as AI and big data. The firm’s portfolio includes notable investments in companies like Coinbase, BlockFi, Figure Technologies, and eToro. They have a strategic focus on emerging technologies and financial services, providing significant support and funding to help these companies scale. Morgan Creek Digital recently raised $80 million for its third fund, emphasizing its commitment to expanding its influence in the blockchain and digital asset space. Morgan Creek Capital's investment strategy is influenced by the Endowment Model, which prioritizes asset allocation, value orientation, and a forward-thinking approach. The firm typically leads investment rounds, providing both capital and strategic guidance to their portfolio companies. This model has helped them achieve successful exits, including those from Kyndi and BlockFi​. The firm is led by experienced professionals including co-founders Mark Yusko and Jason Williams, alongside General Partners Sachin Jaitly and Xavier Segura. Their combined expertise and strategic insight have positioned Morgan Creek as a significant player in the venture capital landscape, particularly within the realm of digital assets and blockchain technology. For startups looking to engage with Morgan Creek Capital, presenting innovative, scalable solutions in blockchain or digital assets with a clear market potential is crucial. The firm values direct and strategic pitches that align with their investment philosophy and long-term vision.

Morningside Ventures is the venture capital investing arm of the Morningside Group, a long-standing private-capital platform founded in 1986 by Hong Kong-American brothers Gerald L. Chan, who serves as Chairman of Morningside Ventures, and Ronnie C. Chan, Chairman of Hang Lung Group. Headquartered in Newton, Massachusetts with additional operations in Hong Kong, the firm deploys patient capital across North America, Asia, and Europe with a long-term orientation and an explicit commitment to ethical practice. Life sciences is the dominant concentration, with the team recognized as a pioneer in oncolytic viral therapy, mitochondrial medicine, and innate-immunity modalities spanning toll-like receptors, the STING pathway, the complement cascade, and immune proteasomes. Portfolio companies have received seven FDA Breakthrough Therapy designations and twelve Fast Track designations — a track record few venture firms in any segment can match. The platform has made roughly 431 disclosed investments in aggregate. Average check sizes by stage are approximately $4.5 million at seed (17 deals), $23.9 million at Series A (42 deals), and $49.2 million at Series B (36 deals). Morningside leads rounds. Recent deals include leading a $105 million round in Cognito Therapeutics in March 2026, a $12 million Series B Plus in Accropeutics in March 2025, an $8.5 million pre-Series A in Ampa in October 2025, and an investment in digital health company Xealth in March 2025. The 2025 calendar saw 10 investments in total. Beyond capital, Morningside's philanthropic commitments to the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design reflect the firm's conviction that deep institutional relationships with leading research universities are essential to discovering and backing the next generation of breakthrough science.

Morpheus Ventures, founded in 2016 and based in Los Angeles, focuses on early-stage investments in cutting-edge technologies such as data analytics, machine learning, robotics, and SaaS. Their portfolio includes innovative companies like Rigetti Computing, Vicarious, and Starship Technologies. The firm has made significant exits including Rigetti Computing and Vicarious (acquired by Alphabet). Other notable investments include HouseCanary, a real estate data analytics company, SafetyCulture, a leading safety and quality inspection software, and Sidecar Health, a health insurance platform. The leadership team at Morpheus Ventures includes experienced investors like Damien Petty, who has a background in artificial intelligence, robotics, and quantum computing, and has led investments in companies like DeepMind (acquired by Google) and Skype (acquired by Microsoft). The team focuses on identifying and nurturing companies with the potential to disrupt their respective industries and drive significant advancements in technology.

Mosaic Ventures, established in 2014 and based in London, focuses on early-stage investments, primarily in Series A rounds, targeting transformative technology startups across Europe. Their portfolio includes notable investments such as Veriff, an AI-based identity verification software; Blockstream, a developer of blockchain-based platforms; and Illumio, which provides cloud workload security solutions. Mosaic Ventures is sector-agnostic, with investments spanning various industries including AI, blockchain, fintech, and enterprise software. They typically invest between $1M to $10M, emphasizing long-term partnerships and market research to support the growth of innovative companies. Key team members include co-founders Simon Levene and Toby Coppel, both of whom have extensive experience in Silicon Valley and Europe. The team also includes Benedict Evans as a venture partner, bringing deep insights from his time at Andreessen Horowitz. For startups, Mosaic Ventures values clear, innovative pitches that showcase strong market potential and technological advancements. They build their investment funnel through proactive scouting and a robust network, aiming to partner with entrepreneurs reimagining the future of technology.

Motec Ventures is an Austrian smart-mobility venture capital firm founded in 2018 and headquartered in Vienna, with offices in Berlin and Munich and an international network across the United States, China, and South Korea. The fund was formed as a joint venture between German automotive management consultancy e&Co. AG and Austrian VC firm Venionaire Capital. Managing Directors Geza Brugger and Berthold Baurek-Karlic lead the firm, with automotive design icon and EV pioneer Henrik Fisker serving on the advisory board. Motec's mission is to invest in technology, process, and service solutions that drive the future of mobility, scaling high-tech and deep-tech startups globally in close partnership with leading automotive companies. The firm focuses on seed-stage startups in automotive, autonomous vehicles, AI, drones, and smart mobility, with check sizes typically between $500,000 and $3 million. As of 2023 Motec had invested in approximately seven companies. Portfolio names include RFISee, an Israeli 4D-imaging-radar startup; FDTech, a German autonomous-driving-algorithmics firm; Autobahn, an Estonian automotive sales platform; Butleroy, an AI scheduling platform from Austria; Firstbird, an Austrian employee-referral platform; Unmanned Life, a defense and drone platform; and B2B auto-sales venture CarFellows. YodelTalk (Yodel.io), a UK voice-computing company, was acquired by Brevo in September 2022 — representing one of the fund's notable exits. Motec maintains co-investment agreements with partners such as Hahn Group, an EUR 2.8 billion AUM asset manager, and draws on the European Super Angels Club network for deal flow and co-investment capacity. The firm's dual Austrian-German management structure and direct automotive industry relationships give portfolio companies a credible entry point into European OEM commercial partnerships.

Motion Ventures is a Singapore-based venture capital fund founded in 2021 by Shaun Hon, a former Royal Dutch Shell engineer who also designed electric vehicles for Amazon, BMW, and Ford. The firm is dedicated to catalyzing digital and energy transitions across global maritime supply chains and is backed by the largest consortium of maritime corporates in the world. Fund I was anchored by Wilhelmsen at S$30 million in 2021 and has already produced two profitable exits, placing it in the top 10% of 2021-vintage VC funds globally. In March 2025, Motion announced Fund II at USD 100 million — the largest maritime-focused tech fund to date — with backing from 17 or more strategic corporate LPs. Fund II deploys checks of USD 250,000 to USD 10 million into at least 25 companies over 18 to 24 months, targeting solutions that digitize and decarbonize the maritime industry. Across both funds the firm has made approximately 29 investments. Portfolio companies include OceanScore (emissions data), Fernride (autonomous port vehicles), Kaiko Systems (Series A, March 2025), ShipIn Systems (invested January 2026), Freightify, Everimpact, Expedock, Harbor Lab, Limbiq, and FrontM. The Motion Ventures Alliance — a network of more than 80 seasoned maritime executives — provides portfolio companies with mentorship, enterprise customer introductions, and pilot opportunities across the global shipping ecosystem. Shaun Hon's engineering background in both legacy energy and electric mobility gives the firm credibility on both sides of the maritime decarbonization challenge: digital optimization and clean propulsion.

Motu Ventures is a Berlin-based seed-stage venture capital fund founded in 2013 and led by General Partners Philipp Semmer and Michael Schmitt, the latter a former Engineering Director at Google. The firm invests in seed-stage deep-tech software companies across Europe, positioning itself as an active operator-partner that provides entrepreneurial guidance, a broad network, and hands-on coaching through the critical early phases. The fund name references the reef islets in Polynesia — formed by broken coral surrounding an atoll — as a metaphor for how Motu nourishes startup ideas and returns capital to investors. Typical deals fall in the $1 million to $5 million range. The fund has invested in approximately ten companies with a focus on AI, digital marketing, travel, and healthcare software. Active portfolio companies include Sharpist (a digital learning platform for employees), Bilendo (accounts receivable management), LiveEO (infrastructure analysis with satellite data, most recent investment June 2024), Mindpeak (AI-based cancer diagnostics), Vivira (remote physical therapy), and Ecoworks (climate-neutral buildings). The firm recorded a notable exit in Opinary — a mobile polling platform with clients including Toyota, Yahoo, Ford, MasterCard, and HuffPost — in July 2023. In October 2021 the Motu team partnered with Earlybird to launch Earlybird-X, a seed fund focused on deep tech, while continuing to actively support the existing Motu Ventures portfolio. The combination of Schmitt's engineering depth and Semmer's legal and operational expertise gives the firm a grounded, practitioner perspective that resonates with technically sophisticated founders building in Europe.

Motus Ventures is an early-stage venture capital firm headquartered in Redwood City, California, focusing on Artificial Intelligence, Climate Tech, and Deep Tech. Founded in 2012, the firm backs startups developing groundbreaking technologies with the potential to transform major industries, particularly in fields like robotics, transportation, and the Internet of Things (IoT). Motus Ventures takes a hands-on approach to investment, often working closely with founders to help them scale. Its partners are engineers and executives with experience building companies from inception through to public listings. The firm also boasts strong connections with major industrial partners, leveraging these relationships to provide strategic guidance and market access for its portfolio companies. Key investments in their portfolio include Elroy Air, an aerospace company, and Orbit Fab, which focuses on in-space fuel infrastructure. Motus Ventures also supports companies in AI and automation, emphasizing the need for scalable technologies that address global challenges, including sustainability. Motus’ strategy involves not just financial backing but also deep involvement in product development and commercialization, making it a critical partner for startups aiming to push technological boundaries. With a commitment to innovation, Motus continues to expand its portfolio, particularly in emerging sectors like green hydrogen and advanced machine learning technologies.

Movens Capital is a Warsaw-based venture capital firm that primarily invests in early-stage and growth companies across Poland and Central Eastern Europe (CEE). Established in 2018, the firm manages two main funds: Movens Venture Capital, which focuses on seed and Series A investments in high-growth technology companies, and Movens Growth Equity, aimed at providing equity capital to scale up digital and consumer-focused small-to-medium enterprises (SMEs). Their investment range typically spans from €2 million to €6 million. Movens Capital specializes in sectors like fintech, SaaS, deep tech, marketplaces, medtech, and e-commerce support. They have a strong track record of supporting startups such as Vue Storefront, Sky Engine AI, and Doctor.One. These investments demonstrate their focus on innovative solutions with global scalability, especially those looking to expand into the U.S. and European markets. The firm is led by partners Artur Banach, Michał Olszewski, and Łukasz Pawłowski, who bring decades of entrepreneurial and investment expertise. They are known for their hands-on support in scaling businesses, providing not only capital but also strategic guidance through initiatives like the Movens Academy and Movens Advisory. These programs offer crucial assistance in areas like pricing strategy, HR, and international expansion to help portfolio companies achieve sustainable growth.

MPM Capital, founded in 1997, is a leading venture capital firm based in Boston and San Francisco, specializing in biotechnology and life sciences investments. The firm has a robust portfolio, having invested in over 150 companies, including notable names like 23andMe, ReNAgade Therapeutics, and Argenx. MPM Capital's focus is on transforming innovative scientific discoveries into breakthrough medicines, particularly in oncology and other high-need therapeutic areas​. MPM Capital recently raised $850 million for its second Oncology Impact Fund, marking it as one of the largest biotech impact investment funds globally. This fund emphasizes investments in companies developing novel cancer therapies, reflecting MPM's deep commitment to addressing significant medical challenges. The firm's team includes seasoned professionals with extensive experience in research, drug development, and corporate strategy. Key team members like Dr. Luke Evnin and Dr. Ansbert Gadicke bring invaluable expertise to the firm, guiding its strategic investments and supporting portfolio companies through various growth stages​ .

MTG Ventures is the dedicated venture capital fund of Modern Times Group MTG AB (Nasdaq Stockholm: MTG.B), a Swedish digital entertainment company headquartered in Stockholm. Since its operational scaling in 2020, MTG Ventures has committed approximately SEK 396 million (roughly USD 40 million) across more than 26 early-stage investments in gaming, esports, and interactive entertainment startups, primarily in the United States and Europe. The fund takes non-controlling minority stakes in high-potential companies, focusing on startup game developers, massively multiplayer online games, and the platforms and tooling that serve them. MTG originally launched the vehicle as a $30 million gaming investment fund and announced USD 11 million in gaming and esports investments in the first half of 2019 alone. Average check sizes run $500,000 to $3 million at seed and Series A. Portfolio companies include Blitz, an esports learning app for League of Legends, Overwatch, and CS:GO; Tonk Tonk Games based in Austin; BITKRAFT Esports Ventures; Runtime, a performance nutrition company for gamers; Sviper, a mobile games studio in Hamburg; and Phoenix Labs, the creator of AAA action RPG Dauntless. MTG's parent portfolio includes InnoGames, Hutch, Ninja Kiwi, Snowprint, and PlaySimple across its Midcore and Casual gaming districts, providing MTG Ventures' portfolio companies with commercial and operational relationships across the global games industry. At Capital Markets Day 2025, MTG announced continued gaming sector expansion synergies, particularly in mobile and midcore games, signaling that MTG Ventures remains an active strategic tool for the parent company's growth agenda.

Mubadala Capital’s Ventures platform stands out as a leading global investor, blending the strengths of Mubadala Investment Company with the agility of a venture capital firm. Focused on technology and healthcare sectors, Mubadala has made over 75 investments, including notable startups like Chroma Medicine, Recursion Pharmaceuticals, and Exscientia. Their strategy revolves around partnering with visionary founders to build enduring companies, leveraging Mubadala’s extensive resources and global scale. Geographically, Mubadala Ventures operates with a significant presence in technology hubs such as San Francisco, London, and Abu Dhabi, ensuring deep integration into the global innovation ecosystem. They emphasize Series A+ investments in the U.S. and Series B+ in Europe, providing substantial capital and strategic support to their portfolio companies. Mubadala's investment strategy is marked by a focus on capital preservation and downside protection, ensuring sustainable growth and returns. The fund typically invests in founder-led companies, with average check sizes tailored to the needs of each growth stage. They are known for their disciplined approach to evaluating opportunities, benefiting from Mubadala's broad network and sovereign backing. The team at Mubadala Ventures includes industry veterans like Ibrahim Ajami, Head of Ventures, and Alaa Halawa, Co-Head of US Ventures. Their expertise spans various sectors and geographies, further strengthening Mubadala’s investment acumen. Startups looking to engage with Mubadala are advised to highlight their alignment with Mubadala’s strategic focus and demonstrate robust business models that can benefit from Mubadala’s vast resources and network.

Mucker Capital, founded in 2012 and headquartered in Los Angeles, is a venture capital firm that invests in seed and early-stage startups across the United States, Canada, and beyond. With additional offices in Austin and Toronto, Mucker Capital focuses on internet-enabled software and services, aiming to support startups outside the traditional Silicon Valley ecosystem. The firm believes that great companies can be built anywhere and provides tactical help, networking opportunities, and a bridge to Silicon Valley resources. Notable portfolio companies include Honey, acquired by PayPal; Surf Air, which went public on NASDAQ; and ServiceTitan, a business management software for home service providers. Mucker Capital has also backed companies like The Black Tux, ServiceTitan, and BloomNation. MuckerLab, their pre-seed accelerator, is highly regarded and ranked second in the U.S. by the Seed Accelerator Rankings Project based on valuations, exits, fundraising, survival, and founder satisfaction. Mucker Capital's approach includes rolling up their sleeves to work alongside entrepreneurs on product development, marketing, sales, recruiting, and other critical areas to help startups succeed. The firm has launched multiple funds, including Mucker III, a $45 million seed-stage fund, and continues to support the growth and scaling of innovative startups.

Munich Re, founded in 1880, is one of the world's leading providers of reinsurance, primary insurance, and risk management solutions. Headquartered in Munich, Germany, the company operates globally, offering comprehensive risk assessment and financial protection across a wide range of sectors. Munich Re has consistently ranked at the top of the global reinsurance industry, thanks to its robust risk management practices, financial stability, and innovative approach to emerging risks. The company’s strategy, known as Ambition 2025, focuses on three core pillars: Scale, Shape, and Succeed. This strategy aims to enhance Munich Re's core business, develop new digital and innovative business models, and deliver added value to shareholders, clients, employees, and communities. The company is particularly focused on expanding its reinsurance operations, modernizing IT infrastructure, and pushing the boundaries of digital solutions, including cybersecurity and the Internet of Things (IoT). In terms of financial performance, Munich Re reported a consolidated result of €4.6 billion for 2023, with a solvency ratio of 267%, reflecting its financial strength and stability. The company is also committed to sustainability, setting ambitious goals to decarbonize its operations and investment portfolio, with the aim of achieving net-zero emissions by 2050. Munich Re’s global presence is supported by over 42,800 employees across more than 50 countries, making it a critical player in managing complex and extraordinary risks worldwide​.

MVP Munich Venture Partners is a Munich-based European venture capital firm founded in 2005 and one of Germany's largest cleantech venture capital specialists. The firm's tagline is 'Driving the eco-industrial revolution,' and it invests in entrepreneurs transforming entire value chains in the most CO2 emission-intensive sectors: energy, mobility, agriculture and food, and industrial technologies. MVP is the Fraunhofer-Gesellschaft's preferred venture capital partner and has historically received support from the European Union's Competitiveness and Innovation Framework Programme. The firm leads rounds and typically deploys checks of $1 million to $10 million at Series A and B. The team is led by Founder and Partner Walter Grassl — an IT veteran, MIT scholar, and PhD in Informatics who previously sold Relayr, Proximetry, Communology, Right Hemisphere, and Visapix — alongside Founder and Venture Partner Rolf Nagel, Partner Martin Kroner, and Partner and CFO Michael Sailer. MVP's portfolio numbers approximately 20 companies with 10 acquisition exits. Notable portfolio companies include Sonnen (smart residential batteries, acquired by Shell), Relayr (industrial IoT, acquired by Teleperformance after raising a $23 million Series B with Munich Re Ventures and Kleiner Perkins), GreenCom Networks, electrochaea (power-to-gas), Fahrenheit (cooling technology), Prolupin (plant-based food), and LuxExcel (3D-printed lenses). With more than 15 years of continuous operation in European cleantech, MVP brings a patient capital model suited to the long development cycles of hardware, energy, and industrial ventures. The firm's Fraunhofer partnership and EU program participation give portfolio companies privileged access to applied research institutions and public co-investment programs, lowering commercial validation costs at critical early stages.

Mustard Seed VC, founded in 2015 by Henry Wigan and Alex Pitt, is a London-based venture capital firm focusing on impact investments. They back innovative businesses that tackle significant social and environmental challenges. Their investment philosophy emphasizes the "lock-step" approach, where the business model inherently benefits society, aligning with their goal of sustainable capitalism. Mustard Seed VC's portfolio includes notable investments such as What3Words, a geocoding system that improves location accuracy, and Winnow Solutions, which uses technology to reduce food waste. The firm has had successful exits, including Lifecake, a family photo-sharing app acquired by Canon. They typically invest in seed and growth stages, with investment sizes ranging from £100,000 to £500,000, and have the capacity to follow on into Series A rounds. Mustard Seed is committed to long-term partnerships, offering extensive support to their portfolio companies. Mustard Seed's impact-driven approach has attracted support from significant backers like Big Society Capital, enhancing their ability to drive capital towards socially impactful ventures. Their guiding principles include fortitude, persistence, humility, and audacity, which they believe are essential for building transformative businesses​.

MVM Partners, founded in 1997, is a global venture capital firm focused on high-growth healthcare investments. With offices in Boston and London, MVM invests broadly across sectors including medical technology, pharmaceuticals, diagnostics, digital health, and other healthcare-related fields. Their portfolio includes notable companies such as SkyCell, which developed patented temperature-control technology for safely transporting vaccines and biotech drugs, and Ossio, which created OSSIOfiber Intelligent Bone Regeneration Technology—a novel orthopedic fixation material that integrates into native bone and avoids the need for permanent metal implants. MVM also invested in MDxHealth, a company specializing in molecular diagnostics for urologic cancers, which enhances personalized cancer diagnosis and treatment. MVM's investment strategy emphasizes significant minority stakes in innovative companies, providing both financial support and strategic guidance to help these companies grow and scale. Their approach involves close collaboration with management teams to drive business development and market expansion. MVM's recent investments include companies like eXmoor Pharma, which focuses on cell and gene therapy services, and Nalu Medical, which develops minimally invasive solutions for chronic pain management. These investments reflect MVM's commitment to supporting advancements in medical technology and improving patient outcomes globally.

Myelin VC is a venture capital firm founded in 2019 with operations across Madrid, Spain, Montevideo, Uruguay, and Buenos Aires, Argentina. The fund's name references the myelin sheath that accelerates neural signals, and its mission centers on backing startups whose ideas reshape how people think, collaborate, and solve problems at scale. Myelin is a $50 million fund that takes an industry-agnostic approach to early-stage technology, writing checks of $250,000 to $1 million from seed through Series A. The team is led by General Partners Matias Nisenson (blockchain gaming and DeFi background), Martin Varsavsky (telecom and fertility entrepreneur), Cesar Levene, and Non-Executive General Partner Alec Oxenford (founder of OLX), with Investment Partner Federico Jack also involved in deal execution. As of November 2024 Myelin had invested in 42 companies spanning healthtech, biotech, food and beverage, SaaS, fintech, AI, and web3. Notable portfolio companies include CookUnity, a rapidly scaling food-tech platform; Daye, a women's health company founded by Valentina Milanova; Aura Biosciences, founded by Elisabeth de Los Pinos (an exit); Buenbit, a fintech founded by Federico Ogue; Pipedream Labs ($13 million round in 2024 alongside Starship Ventures and Cortado Ventures); NUE Life Health (an exit); Nodal ($4 million seed extension, November 2024); Throne (gut-health AI, May 2025); and Midas Software (most recent investment, March 2026). Three companies have exited to date. Myelin's tri-city presence across Madrid, Montevideo, and Buenos Aires anchors it as a genuinely transatlantic fund, with the ability to source from Spain's growing startup ecosystem and Latin America's deep pool of technical and commercial talent simultaneously.

Nasdaq Ventures is the principal strategic and technology venture investment arm of Nasdaq, Inc., founded in 2017 and headquartered in New York City. The program's mandate is to identify and collaborate with companies developing technologies, services, and solutions that align with Nasdaq's clients' needs and the exchange operator's long-term objectives across global capital markets. Investment themes span market infrastructure, data and analytics, anti-financial crime, digital assets and blockchain, AI and machine learning, ESG, and enabling technologies. The fund writes minority-stake checks typically between $1 million and $10 million, investing from seed through late stage. The team is led by Senior Vice President and Head of Nasdaq Ventures Gary Offner, a 30-plus-year private-capital investor who previously served as a Managing Director at Morgan Stanley running Principal Strategic Investments globally for the Institutional Equity Division. He is joined by Vice President Ben Blueweiss, a former eight-year Bloomberg LP veteran, and Principal Yordanka Ilieva. Nasdaq Ventures has made approximately 30 investments. Notable portfolio companies include Juniper Square, which powers 40,000-plus funds, 650,000 LP accounts, and $1 trillion in LP capital, and received a strategic investment as part of its Series D-III in September 2025; Puro.earth, a carbon-removal marketplace; Dasseti, an investor due-diligence platform; Kuberno, an entity-governance solution; Matter, a sustainability reporting platform; and Sporttrade, a sports-event exchange modeled on financial markets. Nasdaq Ventures operates as a collaborative partner rather than a passive LP, offering portfolio companies direct access to Nasdaq's client relationships, regulatory expertise, and global exchange infrastructure. The fund's geographic focus spans the United States and Europe.

Naspers, based in Cape Town, South Africa, is a global consumer internet group and one of the world's largest technology investors. Its diverse portfolio spans over 100 markets, with significant investments in sectors such as e-commerce, fintech, food delivery, and education technology. Key investments include leading companies like Tencent, Delivery Hero, and Udemy. Naspers has also backed innovative startups such as ElasticRun, a B2B platform, and Immutable, a blockchain infrastructure provider. Their strategy involves identifying high-growth opportunities and leveraging their extensive global network to drive value and scale. Naspers operates through its investment arm, Prosus, and maintains a dual listing on the Johannesburg Stock Exchange and Amsterdam's Euronext. Recently, Fabricio Bloisi, formerly head of iFood, was appointed CEO, succeeding Bob van Dijk. The company is known for its active role in nurturing startups, with notable exits like Zomato and Remitly. For startups, Naspers is a strategic partner, offering not just capital but also operational support to accelerate growth and achieve market leadership. Approaching them typically involves highlighting potential synergies with their existing portfolio and demonstrating robust growth potential​.

Nation 1 VC, now branded as N1, is an early-stage venture capital firm founded in 2019 and headquartered in Prague, Czech Republic, with a registered presence in Luxembourg. The firm positions itself as a 'Day 0' investor — the first choice as a first investor and partner — backing AI and healthtech founders primarily across Europe and the United States. N1 is led by founding Managing Partners Marek Moravec and Jaroslav Trojan, alongside partner Petra W. Konceli kova, and manages approximately $60 million across two funds: an original Nation 1 Fund of EUR 35.1 million and a successor vehicle currently being deployed. N1 writes checks from EUR 20,000 to EUR 1.5 million per company as a minority investor at pre-seed and seed stages, and has deployed EUR 23 million or more across 30-plus startups in its first five years of operation. As of late 2025 the active portfolio stands at 35 companies, with 4 new investments made in 2025 alone. The portfolio spans AI, fintech, insurtech, healthtech, e-commerce, travel, and environmental technologies. Notable portfolio companies include Snuggs, a period-underwear brand; Daytrip, a platform connecting travelers with local-knowledge drivers; Vrgineers, a VR training simulator for aviation; DuoCards, a language-learning app; TrueClaim, an insurtech platform; and Myriad AI, a Czech-founded AI startup that raised a $2 million pre-seed as a recent follow-on. N1 operates with conviction at the earliest stages, accepting the highest uncertainty in exchange for the most meaningful ownership and founder relationships. The firm's approach is built on long-term partnership rather than board oversight alone, with partners engaging actively on product, hiring, and early commercial strategy.

NGP Capital, founded in 2005 and headquartered in Palo Alto, California, is a global venture capital firm with a focus on growth-stage technology companies. They have over $1.6 billion under management and invest in sectors such as edge cloud, cybersecurity, digital industry, and digital transformation. Notable investments include Deliveroo, a leading food delivery platform; Moovit, a mobility services company acquired by Intel; and PubMatic, an adtech company that went public in 2020. Other prominent investments are Lime, a scooter rental platform, and Shadowfax, an on-demand hyperlocal delivery service. NGP Capital operates globally, with a significant presence in the U.S., Europe, and Asia. Their portfolio is managed using an AI-powered platform named "Q," which helps identify and rank potential investments based on over 700 growth parameters. The firm is led by experienced partners like Bo Ilsoe, who emphasizes backing ambitious entrepreneurs with a global vision. NGP Capital’s strategy leverages its partnership with Nokia to support portfolio companies with industry insights and market access.

Natural Bridges Ventures (NBV) is a global venture capital firm based in Silicon Valley, specializing in scaling disruptive technologies through a unique blend of strategic guidance and operational acceleration. NBV focuses on early-stage companies that operate at the intersection of communication, collaboration, and technological innovation. With an emphasis on design thinking, the firm partners with startups aiming to transform markets in areas such as IoT, digital health, mobility, and the digital enterprise​. What sets NBV apart is its global network and ability to connect startups with ecosystems across key regions, including the U.S., Europe, Asia, Israel, and Latin America. The firm employs a disciplined, process-oriented approach to ensure rapid market entry and scaling for its portfolio companies. NBV works closely with corporate partners and startups alike, facilitating the integration of external innovation into larger business ecosystems. Their focus on "innovation by design" helps identify untapped opportunities and empower businesses to create lasting, market-shifting solutions​. NBV's portfolio includes high-growth ventures that leverage cutting-edge technologies to address critical challenges across multiple sectors. By nurturing startups with both strategic investment and hands-on operational support, NBV accelerates their journey from concept to commercialization. With a cross-functional team of experienced entrepreneurs and corporate executives, the firm offers both financial and strategic resources, ensuring that their portfolio companies can navigate complex markets and achieve sustained growth on a global scale.

Navigare Ventures, founded in 2021 and based in Stockholm, is an early-stage venture capital firm specializing in science-driven companies. As a subsidiary of Wallenberg Investments AB, Navigare Ventures focuses on deep tech sectors, including advanced computing, quantum technologies, synthetic biology, bio innovation, and data-driven life sciences. The firm is committed to investing in transformative technologies that have a strong industrial and societal impact. Navigare Ventures typically invests in Seed and Series A rounds, partnering closely with founders to support the growth and development of their companies. The firm has a robust portfolio that includes companies like Elypta, a startup developing metabolism-based liquid biopsy technology for cancer detection, and EnginZyme, which focuses on sustainable biomanufacturing. Their investment strategy is characterized by long-term partnerships, leveraging an extensive network of scientific and industrial expertise to help startups scale and succeed in their respective fields​.

Navigate Ventures is an early-growth stage venture capital firm founded in 2020 and headquartered in Beverly Hills, California, with offices in Los Angeles and London. The firm is built around a distinctive 'A Extension Round' thesis: it specializes in B2B enterprise SaaS companies outside Silicon Valley that have cleared early venture risk — proven product-market fit, a repeatable go-to-market motion, capital efficiency, and typically $2 million or more in ARR — but have not yet attracted the scale of growth capital their trajectory warrants. Navigate is led by Founder and Managing Partner Ivan Nikkhoo, whose partnership brings more than 130 combined years of investing, advising, and operating experience in enterprise software and has returned over $1 billion in shareholder value to LPs. The fund reports more than $600 million in assets under management and has made 45 investments, with 31 committed in the trailing three years. It writes initial checks of $3 million to $10 million, scaling to $10 million to $50 million in follow-on as portfolio companies grow. The portfolio clusters into enterprise applications, vertical SaaS, AI industry applications, and fintech. Notable companies include HealNow, an enterprise pharmacy customer-management and payments platform; Quincus, an AI orchestration platform for digital supply chain operations; and Zuub, a dental revenue cycle management solution. Navigate is also pioneering the application of AI across all four stages of the venture lifecycle: sourcing, diligence, portfolio management, and exit strategy. Navigate's core thesis is that the best enterprise SaaS opportunities are consistently overlooked because they are built outside the Bay Area. The firm's geographic and stage focus, paired with its deep operational network, allows it to identify and support market leaders that would otherwise be undercapitalized.

Naxicap Partners, a subsidiary of Natixis Private Equity, is a leading French private equity firm managing €6.7 billion in assets as of the end of 2022. The firm focuses on mid-cap buyouts and small-cap growth investments across diverse sectors including healthcare, technology, real estate, and business services. They are known for supporting companies with strong growth potential and stable business models, adapting their investment focus based on sectoral economic dynamics. Notable investments in Naxicap's portfolio include Advanced Accelerator Applications, a developer of molecular nuclear medicine theragnostics, and Alltub, a manufacturer of collapsible aluminum tubes. The firm has also seen successful exits such as the sale of Maxi Bazar to the Zouari family group and House of HR to Bain Capital. Naxicap has a strong commitment to ESG principles, having received the highest rating from the UN Principles for Responsible Investment for Strategy & Governance. They focus on incorporating ESG issues into their investment analyses and ownership policies, promoting sustainability within the investment industry.

NCL Technology Ventures is a UK-based venture capital firm specializing in early-stage investments across the healthcare and life sciences sectors. Founded in 2010, the firm focuses on identifying and backing companies that are driving transformational change in healthcare, with a particular emphasis on innovation in areas such as therapeutics, medical technologies, and digital health. NCL's mission is to foster companies that are developing breakthrough solutions to address global health challenges, from preventive care to cutting-edge treatments​. The firm's investments typically range between €1.5M and €3M, with a strong focus on seed and Series A funding. NCL is deeply involved in the strategic development of its portfolio companies, providing both capital and operational expertise to help them navigate the complexities of the healthcare landscape. The firm's portfolio includes companies like TC BioPharm, which is pioneering allogeneic cell therapies, and Curesponse, a precision medicine startup. With offices in London and the US, NCL is well-positioned to support its portfolio globally, fostering partnerships and driving innovation in both European and American markets. Their team, led by experienced venture capitalists like Jerry Biggs and Jonathan Synett, brings decades of investment and entrepreneurial expertise to the table.

NEM Ventures is the venture capital and investments arm of the NEM blockchain ecosystem, founded in 2018 and based in Gibraltar. The firm was created following a public community vote that mandated NEM Ventures to manage a pool of reserved funds and deploy them as strategic investments in projects aligned with NEM's ethos — specifically those building on NEM's NIS1 and Symbol blockchain protocols. NEM Ventures was led by Founder and General Partner Kailin O'Donnell and operated with a lean two-person team. The fund concentrated on seed and early-stage companies in the blockchain, cryptocurrency, and fintech sectors, with a geographic emphasis on New Zealand and Switzerland. Investment criteria prioritised projects with truly differentiated products, founders committed to advancing the blockchain ecosystem, and business models capable of generating positive net income in the medium term. NEM Ventures also ran the NEM Ignite Incubator Programme, a virtual incubator for early-stage companies building on NIS1 or Symbol that launched its first cohort in 2021. The firm made 9 disclosed investments. Notable portfolio companies include Techemy, a holding company for a blockchain and distributed-ledger enterprise ecosystem whose subsidiaries include Brave New Coin, Blockchain Labs, and Sphere Identity; Vimba, a cryptocurrency savings platform; StakeHound, which received a seed investment in January 2021; and SharpShark, a blockchain time-stamping platform for intellectual property protection and tokenisation. NEM Ventures' last disclosed investment was in early 2021, and the fund is now inactive. It remains a notable example of community-governed venture capital deployed to accelerate adoption of a specific blockchain ecosystem.

NeuHelium is an innovative venture capital firm that focuses on investments in advanced technology sectors, particularly those related to brain-inspired intelligence and AI-based chips. The firm aims to build a robust industrial development engine powered by cutting-edge AI technologies. This approach aligns with their vision of leveraging artificial intelligence to create significant advancements in various industries, ensuring a transformative impact on the market. NeuHelium specializes in providing early-stage financing, helping startups develop from initial concepts to viable products. Their investment strategy is centered on high-growth potential startups that exhibit strong market demand and innovative solutions. By offering seed financing, NeuHelium supports startups in conducting market research, developing prototypes, and covering essential operational expenses. This high-risk investment strategy is balanced by the potential for substantial returns if the startups succeed, much like other venture capital funds that focus on early-stage investments​.

Neulogy Ventures, established in 2014 and based in Bratislava, Slovakia, is a Luxembourg-regulated venture capital fund. The firm focuses on early-stage tech companies, particularly those operating in Slovakia and the Central and Eastern Europe (CEE) region. Neulogy Ventures manages €65 million in assets, with a diverse portfolio spread across 10 countries. The fund targets investments in sectors like media, cleantech, data analytics, productivity applications, medtech, infrastructure, fintech, security, 3D, e-commerce, and new energy. Neulogy Ventures aims to support mission-driven entrepreneurs with bold ideas that push technological frontiers, particularly those addressing climate change and healthcare challenges. Neulogy Ventures emphasizes a hands-on approach, offering strategic guidance, business development support, and fundraising assistance to its portfolio companies. The firm values long-term partnerships, prioritizing shared values and a collaborative approach over quick exits. Notable companies in Neulogy's portfolio include GA Drilling, GreenWay, and GroupSolver. The team, led by managing partners Christian Mandl and Jaroslav Luptak, brings extensive experience in entrepreneurship, fundraising, and business development, ensuring robust support for their investees.

Neva SGR, founded in 2020, is the venture capital arm of Intesa Sanpaolo Group, one of Italy's largest banking institutions. Based in Turin, Neva focuses on investing in technology-driven companies at various stages, from seed to Series C. The firm is sector-agnostic but leans heavily towards fintech, deeptech, ESG transition technologies, and core tech innovations. With two main funds—Neva First and Neva First Italia—the firm targets both Italian and international startups. Neva First focuses on global opportunities, with a minimum of 30% invested in Italian companies, while Neva First Italia co-invests with a more localized emphasis on Italian startups. The funds have a combined budget of around €500 million, with an average ticket size of €4-10 million per investment. Neva SGR is particularly active in life sciences and deeptech, with notable portfolio companies including D-Orbit in space logistics and Tr1X, a biotech firm focused on autoimmune therapies. The firm’s mission is to foster innovation that addresses global challenges while boosting the Italian and European tech ecosystems.

NAV.VC, formerly known as New Atlantic Ventures, is a venture capital firm based in Reston, Virginia. Founded in 1999, the firm has a strong focus on investing in seed and early-stage companies, particularly those operating in the technology sector. NAV.VC’s investment strategy centers around emerging and disruptive consumer trends, with key sectors including cybersecurity, digital health, fintech, e-commerce, education technology, and advertising technology. The firm is known for its hands-on approach, working closely with portfolio companies to help them navigate the challenges of early growth and scale their operations effectively. NAV.VC leverages its extensive network and deep industry expertise to provide strategic guidance, mentoring, and support to its portfolio companies, aiming to drive their success in highly competitive markets. NAV.VC’s portfolio features a diverse range of companies that are at the forefront of innovation in their respective fields. The firm has a track record of identifying promising startups with the potential to disrupt traditional industries and create significant value for both customers and investors. By investing in companies that align with emerging market trends, NAV.VC positions itself as a forward-thinking venture capital firm that is deeply committed to fostering innovation and supporting the next generation of tech entrepreneurs.

VisVires New Protein, recently rebranded as Clay Capital, is a Singapore-based venture capital firm dedicated to transformative investments in the agrifood tech sector. Founded in 2014, Clay Capital focuses on supporting innovative startups that address fundamental challenges in the food system, particularly in the areas of sustainable packaging, fermentation, agricultural biologicals, crop disease resistance, soil health, and regenerative agriculture. Notable investments include French biostimulant producer Toopi, Israeli bioherbicide startup WeedOUT, and French kitchen robot manufacturer Cook-e. These investments reflect Clay Capital's commitment to leveraging technology to improve sustainability and efficiency in the food and agriculture sectors. Clay Capital's strategy involves investing in early-stage to growth-stage startups, typically with initial checks ranging from $3 million to $8 million, and reserving additional capital for follow-on investments. The firm serves as a bridge between the Asian and European markets, providing startups with support to access and expand in these regions. The rebranding from VisVires New Protein to Clay Capital signifies a renewed focus on building a healthy and sustainable food system, symbolizing fertile ground for growth and innovation. With a newly raised $145 million fund, Clay Capital is well-positioned to continue driving impactful changes in the agrifood tech landscape

NewSpace Capital is a space-focused venture capital firm that invests in growth-stage companies at the intersection of space technology and sustainable development. With a focus on scalable technologies and established revenues, NewSpace targets businesses that leverage space applications to address critical global challenges, including climate change, environmental monitoring, and resource management. The firm typically invests between €10 to €20 million in companies that are ready to scale their operations, offering both financial support and strategic expertise. NewSpace Capital operates with a “picks & shovels” strategy, concentrating on key areas like satellite communications, earth observation, remote sensing, advanced analytics, and space infrastructure. Their approach minimizes risk by backing companies that have moved beyond technical and market entry barriers, ensuring they are poised for significant growth. Portfolio companies like ICEYE, which specializes in Synthetic Aperture Radar (SAR) technology for earth observation, and Kayrros, a leader in environmental intelligence, highlight NewSpace’s commitment to leveraging space technology for tangible impacts on Earth. The firm is led by a team of multidisciplinary experts with deep industry connections, allowing them to access exclusive deals in underinvested segments of the space market. With a target fund size of €250 million, NewSpace Capital aims to drive the next wave of innovation in space while addressing pressing global issues, positioning itself as a key player in the rapidly expanding space economy.

NewSpring Capital, founded in 1999 and headquartered in Radnor, Pennsylvania, is a private equity firm focusing on growth equity, mezzanine capital, healthcare, and buyouts. The firm manages approximately $3.5 billion in assets and has invested in over 250 companies across various sectors. Notable investments in NewSpring's portfolio include Vacasa, a leading vacation rental management company; Innovid, a video marketing platform; and Nutrisystem, a weight management company. These investments reflect NewSpring's strategy of supporting high-growth companies in business services, healthcare, information technology, and consumer products. NewSpring Capital operates through multiple strategies, including NewSpring Growth, which targets high-growth technology companies; NewSpring Healthcare, focusing on innovative healthcare services and technology; and NewSpring Mezzanine, providing capital for acquisitions and recapitalizations. The firm's comprehensive approach allows them to support companies at different stages of their lifecycle, from early growth to expansion.

New Venture Partners is a global venture capital firm that specializes in transforming corporate R&D assets into standalone businesses. The firm focuses on leveraging cutting-edge innovations from large technology companies and spinning them out into independent ventures. With a unique approach, New Venture Partners works closely with corporate partners to identify high-potential technologies that may not align with the company's core business but have significant market opportunities. The firm invests primarily in sectors such as telecommunications, IT, semiconductors, and digital media, emphasizing deep tech and transformative innovations. Their portfolio includes companies that emerged from major R&D labs, such as Bell Labs and British Telecom, showcasing their expertise in corporate spinouts. New Venture Partners typically invests in early-stage startups, guiding them from the incubation phase through to commercialization. Their team brings a wealth of experience from both the corporate and entrepreneurial worlds, providing a mix of strategic guidance and operational support to help ventures scale. With offices in the U.S. and Europe, New Venture Partners has a global reach and focuses on markets across both continents. Their strategy revolves around aligning with corporate partners to unlock the commercial potential of underutilized technologies, ultimately creating high-value businesses that deliver strong financial returns. The firm has established a reputation as a leader in corporate venture capital, with a track record of successful exits and long-term value creation.

New Wave Ventures is a dynamic, privately-owned venture capital fund based in London. Focused on investing in companies with significant growth potential, New Wave targets initial investments ranging from £500,000 to £2,000,000. Unlike many funds, New Wave Ventures invests its own capital without relying on external investors, allowing for a more flexible and long-term investment approach. Their investment philosophy centers on the belief that great businesses are built by great people. New Wave Ventures seeks entrepreneurs who can overcome obstacles and dominate their markets on a global scale. They prefer to co-invest with like-minded partners but often opt to be the sole investor alongside committed owner-managers. This fund is not driven by short-term exits or leverage; instead, it focuses on sustainable growth and strategic support​. Geographically, New Wave Ventures concentrates on the UK, particularly the North West region, encompassing cities like Manchester and Liverpool. Their goal is to fill the funding gap for early-stage and scale-up businesses in these areas, fostering innovation and growth​. The leadership team at New Wave brings a wealth of experience in running successful businesses and tackling various challenges. Their approach involves minimal interference in day-to-day operations, instead offering strategic guidance and financial support. Startups can reach out directly via email for potential investment opportunities​. This combination of substantial financial backing, strategic expertise, and a people-first philosophy makes New Wave Ventures a compelling partner for ambitious entrepreneurs looking to scale their businesses.

Newfund Capital, founded in 2008, is an entrepreneurial venture capital firm with a strong presence in both Paris and Silicon Valley. With $300 million in assets under management, Newfund focuses on seed-stage startups driving global change. Notable investments include Aircall, Fairmoney, and In2Bones, showcasing their diverse and impactful portfolio. The firm invests primarily in technology, precision medicine, personalized treatment, and brain tech sectors. They emphasize early-stage investments, aiming to support startups from the seed stage through international expansion, particularly in France and North America. Newfund's strategy involves quick decision-making, often providing term sheets within three weeks. They seek entrepreneurs with a global mindset and provide significant value beyond capital, including scaling opportunities, networking, and strategic support. The average check size varies but is tailored to meet the needs of each startup, with Newfund often leading the investment rounds. The team includes key members like Henri Deshays and Patrick Malka, who bring extensive entrepreneurial and investment experience. The team is split between their Paris and Palo Alto offices, allowing them to maintain a strong presence in both Europe and the U.S. For startups looking to scale rapidly with a partner who understands the entrepreneurial journey, Newfund Capital offers a compelling blend of expertise, resources, and strategic guidance.

Newion is a pan-European early-stage venture capital firm based in Amsterdam, specializing exclusively in business software. Since its founding in 2000, Newion has invested in over 60 startups, helping companies like Collibra, Deliverect, and Foleon emerge as market leaders in their sectors. Their primary focus is on innovative B2B software companies within the Benelux, Nordics, and Germany. Newion's investment strategy involves participating in seed rounds and Series A funding, providing both capital and hands-on support to help startups scale. The firm manages a total of €300 million in assets across several funds, with their latest, Newion IV, launching with an initial closing of €130 million. The Newion team includes seasoned professionals such as Patrick Polak and Frank Claassen, who bring extensive experience in venture capital and corporate finance. Their approach is characterized by a no-nonsense mentality and a deep commitment to helping their portfolio companies achieve significant growth and market leadership.

Newton Biocapital is a Brussels-based venture capital firm with a strong presence in both Europe and Japan, focusing exclusively on the life sciences sector. Established in 2017, the firm’s investment strategy is centered on supporting companies that tackle chronic diseases, with an emphasis on oncology, metabolic diseases, and neurological conditions. Newton Biocapital plays a hands-on role in its portfolio companies, often leading funding rounds and taking board positions to guide scientific and clinical strategies​. The firm manages two funds—Newton Biocapital I (€114M) and Newton Biocapital II, which is currently targeting €150M. NBC I invested in 14 companies across Europe and Japan, including university spin-offs like Epics Therapeutics and ChromaCure in Belgium, and biotech firms like EditForce in Japan. Newton's approach is deeply integrated with the local ecosystems in both regions, leveraging their strong ties to academic institutions, industry experts, and international investors to facilitate cross-border growth and exits​. Newton’s team combines scientific, regulatory, and investment expertise, led by CEO Alain Parthoens. With offices in Brussels and Tokyo, they are uniquely positioned to bridge the innovation pipeline between Europe and Japan, driving impactful advancements in life sciences​.

Newzone Ventures is a pan-European early-stage venture capital fund headquartered in Lisbon, Portugal, with an office in London, formed in 2021 through the merger of UK-based Newzone and Portugal-based LC Ventures. The firm is led by Managing Partners David Boulton and Pedro Falcao, supported by a lean team of approximately four distributed across Portugal and the United Kingdom. At the time of the merger the combined platform brought together a portfolio of roughly 40 tech startups and more than $30 million in discretionary capital; the firm subsequently earmarked a new $60 million fund to target overlooked markets and founders across Europe. Newzone invests primarily at pre-seed and seed into Portugal- and UK-based startups building technology-led, category-defining, and sustainable businesses, writing checks from $100,000 to $3 million. The firm's three pillars — founder focus, tech-enabled, and sustainable — reflect a conviction that durable businesses require long-term collaborative capital, meaningful product differentiation, and business model resilience. Partners bring two decades of institutional investing and operating experience and have been involved with companies including WeJo, Hero (acquired by Klarna), GitLab, and Feedzai, Portugal's fintech unicorn. As of early 2023 the firm had made approximately 30 disclosed investments. Notable current portfolio companies include Networkme, with an average round investment of approximately $992,000; Visor.ai, a conversational AI platform; and Universal Cover. Newzone Ventures positions itself as an open and transparent partner, offering founders practical advice on development, operations, and team building alongside capital. The firm's dual-city presence across Lisbon and London gives it coverage of two of Europe's most active startup ecosystems.

Nexit Ventures is Finland's oldest and most experienced technology growth capital firm, founded in 1999 and headquartered in Helsinki with a deep presence in Silicon Valley and ecosystem connections into Austin, Texas. The firm describes itself as a Nordic and Transatlantic 'Activist VC' focused on digital transformation, investing primarily in later-stage B2B software and technology companies where its historical success ratio has been close to 80% — well above industry averages. Nexit was co-founded by Artturi Tarjanne, who brings more than 30 years of international IT experience and is one of Finland's pioneering software entrepreneurs, alongside Michel Wendell, Pekka Salonoja, and Risto Siilasmaa — the latter being the former Chairman of Nokia. Current partners also include Sami Karppinen and Risto Yli-Tainio. Nexit manages three fund vehicles totaling roughly EUR 173 million in direct capital, plus a EUR 110.8 million joint operation with 3TS Capital Partners formalised in October 2021: Nexit Infocom 2000 (EUR 66.7 million), Nexit Infocom II (EUR 85 million), and Nexit III (EUR 21.6 million). The firm has made 44 total investments, currently manages 22 active portfolio companies, and has produced 12 exits including acquisitions by Google, Hewlett-Packard, and Nvidia. By geography the portfolio is concentrated in the United States (9 investments) and Finland (6). Notable portfolio companies include Boksi Solutions, which received a Series A follow-on in October 2023; Funambol; Aava Mobile, exited in September 2021; and Aino Health AB, in which Nexit III purchased a 29% stake. Nexit's Activist VC model means the firm takes an unusually engaged role — working directly on strategy, commercial development, and team building alongside portfolio management teams rather than limiting its contribution to board oversight.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

NextWorld Capital, founded in 2009 and headquartered in San Francisco, is a venture capital firm that invests in early to growth-stage companies, particularly focusing on enterprise software, analytics, fintech, and telecommunications sectors. The firm is renowned for its hands-on approach in helping startups scale, often participating in follow-on rounds to support ongoing growth. Notable investments in NextWorld Capital's portfolio include Aircall, a cloud-based voice platform for managing customer support and sales calls; Stampli, an AI-driven AP automation company; and Honeycomb, which provides analytics and observability tools for software developers. Other significant investments are Spiff, a sales commission software, and Routefusion, a fintech company specializing in cross-border payments. The firm is known for its collaborative investment approach, often co-investing with other prominent venture capital firms to maximize the potential of its portfolio companies. NextWorld Capital has successfully nurtured numerous startups to significant growth stages, ensuring they achieve their full potential through strategic guidance and resources.

ND Capital, formerly known as NanoDimension, is a venture capital firm established in 2002, headquartered in Woodside, California. The firm focuses on investing in disruptive technologies across the life sciences, physical sciences, and data sciences sectors. Their core belief is that significant breakthroughs will arise from the convergence of these scientific disciplines. The firm is led by founder and CEO Aymeric Sallin, who has been pivotal in steering the company towards successful investments. ND Capital supports early to mid-stage companies, particularly those developing innovative and market-disruptive technologies. Their investment strategy targets companies at the forefront of scientific advancements that hold the potential to create substantial impact. ND Capital's diverse portfolio includes investments in companies like Natron Energy, Tarveda Therapeutics, Selecta Biosciences, and SQZ Biotech. The firm has a strong track record with numerous successful exits, such as the acquisition of Serotiny by Johnson & Johnson and Icosavax's IPO. The team at ND Capital consists of experienced professionals with deep expertise in various scientific and industrial fields. This includes Senior Partner Patrick Aebischer, who has extensive experience in biotechnology and academic leadership, and Partner Eric Moessinger, who focuses on life sciences investments. ND Capital's mission is to back visionary founders and innovative startups that push the boundaries of science and technology, driving forward transformative solutions that address global challenges..

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.